Latest news with #Lynch
Yahoo
11 hours ago
- Business
- Yahoo
Suncoast Equity Management Appoints Eric Lynch as Managing Director of Institutional Asset Management
Alongside his leadership role, Mr. Lynch will join the firm's Investment Committee to help guide long-term strategy and portfolio oversight TAMPA, Fla., July 29, 2025--(BUSINESS WIRE)--Suncoast Equity Management, a boutique investment management firm with a growing presence in the intermediary distribution space, today announces the appointment of Eric Lynch as Managing Director of its Institutional Asset Management business. Mr. Lynch will also join the firm's Investment Committee, where he will help shape investment strategy and contribute to portfolio decision-making. In his role at Suncoast, Mr. Lynch will serve as a member of the portfolio management team for the firm's flagship Suncoast Select Growth and Suncoast Small to Mid-Cap portfolios and contribute to the Suncoast Dividend Growth portfolio. Additionally, he will lead the firm's institutional channel, overseeing business development, strategy messaging and relationship management. He will play a key role in expanding Suncoast's presence within the intermediary distribution space by cultivating and strengthening partnerships with financial advisors, consultants, and institutional clients. In addition to his leadership role, Mr. Lynch will become a key equity stakeholder in Suncoast, alongside other executives, a step that reflects his deep alignment with the firm's mission and his integral role in shaping its long-term leadership and strategic direction. "What really sets Suncoast apart is its disciplined, focused investment approach combined with a sincere commitment to building lasting relationships—with both individual investors and institutional partners," said Mr. Lynch. "I'm excited to join a team that values integrity and thoughtful decision-making, and to help grow the business while honoring the time-tested principles that have driven Suncoast's success for decades." Mr. Lynch brings over 20 years of experience in equity research, investment strategy, and institutional client service. He joins Suncoast from Scharf Investments LLC, where he served on the Investment Committee and led strategy communications and business development efforts. At Scharf, he was the primary analyst for companies in the Quality Value Portfolio and contributed to both the Multi-Asset and Global portfolios. Early in his tenure at Scharf, he managed the Quality Growth portfolio for several years. He is a frequent guest on CNBC, Bloomberg and Reuters, among other media outlets, and has been quoted often in The Wall Street Journal and Barron's. He will continue to serve on the Scharf Advisory Board until further notice to ensure a smooth transition and foster continued collaboration between the two firms. Earlier in his career, Mr. Lynch founded and led Lynch Capital Management LLC, a registered investment advisory firm where he followed a quality growth strategy. He also held roles as co-chief operating officer, portfolio manager, and research analyst at Polen Capital Management. Leveraging his deep industry experience, Mr. Lynch will collaborate closely with the investment team to identify opportunities, strive to enhance portfolio construction, and ensure alignment with the firm's disciplined investment philosophy. His leadership is expected to drive growth, foster client trust, and support Suncoast's commitment to delivering tailored investment solutions that help meet the evolving needs of its diverse client base. "We are excited to welcome Eric to our leadership team," said Donald R. Jowdy, Founder and Chief Investment Officer of Suncoast Equity Management. "We first worked closely together at Polen Capital with David Polen and have been friends for 20 years. His deep expertise in quality-oriented investing and commitment to long-term client success align perfectly with our firm's mission. I am confident that the addition of Eric will strengthen our investment process and enhance the value we deliver to our clients." Mr. Lynch's appointment follows the firm's recent launch of its first actively managed exchange-traded fund (ETF), the Suncoast Select Growth Fund (NYSE: SEMG), which began trading in May. The ETF represents a significant milestone for Suncoast as it broadens access to its time-tested investment strategy through a modern, tax-efficient vehicle. With SEMG and the continued expansion of its institutional intermediary business, Suncoast is strengthening its platform to meet growing demand from advisors and institutions. Mr. Lynch's leadership will be instrumental in supporting this next phase of growth while reinforcing the firm's commitment to delivering disciplined, research-driven investment solutions. For more information about Suncoast Equity Management, please visit About Suncoast Equity Management Founded in 1997, Suncoast Equity Management is a Tampa-based investment management firm specializing in long-term portfolio strategies and comprehensive wealth planning. Through its proprietary Disciplined Investment System (SEM-DIS), Suncoast Equity Management strives to deliver consistent, research-driven results for individuals, families, and institutional partners. With a commitment to transparency, partnership, and performance, Suncoast Equity Management helps clients build and preserve lasting wealth. To learn more, please visit Important Information Investments involve risk. Principal loss is possible. The Fund's investment objectives, risks, charges and expenses must be considered carefully before investing. This and other important information is contained in the prospectus, which may be obtained by following the links Prospectus and Summary Prospectus or by calling +1.813.963.0502. Please read the prospectus carefully before investing. An investment in the Fund involves risk. There is no assurance that the Fund will achieve its investment objective. An investor may lose money by investing in the Fund. The following are the principal risks of investing in the Fund. The Fund is actively managed and is subject to the risk that the strategy may not produce the intended results. The Fund is new and has a limited operating history to evaluate. Large-Capitalization Companies Risk. The stock of large-capitalization companies may trail the returns of the overall stock market, both in the long and short term. Growth Investing Risk. The stock of growth companies may be more volatile than other types of investments, both in the long and short term. Value Style Investing Risk. Investing in value stocks presents the risk that the stocks may not achieve their full market value. Mid-Capitalization Companies Risk. Investing in the stock of mid-capitalization companies involves greater risk, generally, than that associated with investing in larger, more established companies. The stock may be more volatile and less liquid and be more sensitive to changing market conditions. New Fund Risk. The Fund is a recently organized investment company with no operating history. As a result, investors have no track record or history on which to base their investment decisions. The Fund is distributed by Quasar Distributors, LLC. The fund's investment advisor is Empowered Funds, LLC, which is doing business as ETF Architect. Suncoast Equity Management serves as the Sub-adviser to the Fund. Quasar is not affiliated with ETF Architect or Suncoast Equity Management. View source version on Contacts MEDIA CONTACTS: Meaghan McNicholmeaghan@ (412) 720-3777 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
11 hours ago
- Business
- Business Wire
Suncoast Equity Management Appoints Eric Lynch as Managing Director of Institutional Asset Management
TAMPA, Fla.--(BUSINESS WIRE)-- Suncoast Equity Management, a boutique investment management firm with a growing presence in the intermediary distribution space, today announces the appointment of as Managing Director of its Institutional Asset Management business. Mr. Lynch will also join the firm's Investment Committee, where he will help shape investment strategy and contribute to portfolio decision-making. "What really sets Suncoast apart is its disciplined, focused investment approach combined with a sincere commitment to building lasting relationships—with both individual investors and institutional partners." In his role at Suncoast, Mr. Lynch will serve as a member of the portfolio management team for the firm's flagship Suncoast Select Growth and Suncoast Small to Mid-Cap portfolios and contribute to the Suncoast Dividend Growth portfolio. Additionally, he will lead the firm's institutional channel, overseeing business development, strategy messaging and relationship management. He will play a key role in expanding Suncoast's presence within the intermediary distribution space by cultivating and strengthening partnerships with financial advisors, consultants, and institutional clients. In addition to his leadership role, Mr. Lynch will become a key equity stakeholder in Suncoast, alongside other executives, a step that reflects his deep alignment with the firm's mission and his integral role in shaping its long-term leadership and strategic direction. 'What really sets Suncoast apart is its disciplined, focused investment approach combined with a sincere commitment to building lasting relationships—with both individual investors and institutional partners,' said Mr. Lynch. 'I'm excited to join a team that values integrity and thoughtful decision-making, and to help grow the business while honoring the time-tested principles that have driven Suncoast's success for decades.' Mr. Lynch brings over 20 years of experience in equity research, investment strategy, and institutional client service. He joins Suncoast from Scharf Investments LLC, where he served on the Investment Committee and led strategy communications and business development efforts. At Scharf, he was the primary analyst for companies in the Quality Value Portfolio and contributed to both the Multi-Asset and Global portfolios. Early in his tenure at Scharf, he managed the Quality Growth portfolio for several years. He is a frequent guest on CNBC, Bloomberg and Reuters, among other media outlets, and has been quoted often in The Wall Street Journal and Barron's. He will continue to serve on the Scharf Advisory Board until further notice to ensure a smooth transition and foster continued collaboration between the two firms. Earlier in his career, Mr. Lynch founded and led Lynch Capital Management LLC, a registered investment advisory firm where he followed a quality growth strategy. He also held roles as co-chief operating officer, portfolio manager, and research analyst at Polen Capital Management. Leveraging his deep industry experience, Mr. Lynch will collaborate closely with the investment team to identify opportunities, strive to enhance portfolio construction, and ensure alignment with the firm's disciplined investment philosophy. His leadership is expected to drive growth, foster client trust, and support Suncoast's commitment to delivering tailored investment solutions that help meet the evolving needs of its diverse client base. 'We are excited to welcome Eric to our leadership team,' said Donald R. Jowdy, Founder and Chief Investment Officer of Suncoast Equity Management. 'We first worked closely together at Polen Capital with David Polen and have been friends for 20 years. His deep expertise in quality-oriented investing and commitment to long-term client success align perfectly with our firm's mission. I am confident that the addition of Eric will strengthen our investment process and enhance the value we deliver to our clients.' Mr. Lynch's appointment follows the firm's recent launch of its first actively managed exchange-traded fund (ETF), the Suncoast Select Growth Fund (NYSE: SEMG), which began trading in May. The ETF represents a significant milestone for Suncoast as it broadens access to its time-tested investment strategy through a modern, tax-efficient vehicle. With SEMG and the continued expansion of its institutional intermediary business, Suncoast is strengthening its platform to meet growing demand from advisors and institutions. Mr. Lynch's leadership will be instrumental in supporting this next phase of growth while reinforcing the firm's commitment to delivering disciplined, research-driven investment solutions. For more information about Suncoast Equity Management, please visit About Suncoast Equity Management Founded in 1997, Suncoast Equity Management is a Tampa-based investment management firm specializing in long-term portfolio strategies and comprehensive wealth planning. Through its proprietary Disciplined Investment System (SEM-DIS), Suncoast Equity Management strives to deliver consistent, research-driven results for individuals, families, and institutional partners. With a commitment to transparency, partnership, and performance, Suncoast Equity Management helps clients build and preserve lasting wealth. To learn more, please visit Important Information Investments involve risk. Principal loss is possible. The Fund's investment objectives, risks, charges and expenses must be considered carefully before investing. This and other important information is contained in the prospectus, which may be obtained by following the links Prospectus and Summary Prospectus or by calling +1.813.963.0502. Please read the prospectus carefully before investing. An investment in the Fund involves risk. There is no assurance that the Fund will achieve its investment objective. An investor may lose money by investing in the Fund. The following are the principal risks of investing in the Fund. The Fund is actively managed and is subject to the risk that the strategy may not produce the intended results. The Fund is new and has a limited operating history to evaluate. Large-Capitalization Companies Risk. The stock of large-capitalization companies may trail the returns of the overall stock market, both in the long and short term. Growth Investing Risk. The stock of growth companies may be more volatile than other types of investments, both in the long and short term. Value Style Investing Risk. Investing in value stocks presents the risk that the stocks may not achieve their full market value. Mid-Capitalization Companies Risk. Investing in the stock of mid-capitalization companies involves greater risk, generally, than that associated with investing in larger, more established companies. The stock may be more volatile and less liquid and be more sensitive to changing market conditions. New Fund Risk. The Fund is a recently organized investment company with no operating history. As a result, investors have no track record or history on which to base their investment decisions. The Fund is distributed by Quasar Distributors, LLC. The fund's investment advisor is Empowered Funds, LLC, which is doing business as ETF Architect. Suncoast Equity Management serves as the Sub-adviser to the Fund. Quasar is not affiliated with ETF Architect or Suncoast Equity Management.
NZ Herald
16 hours ago
- NZ Herald
Repeat sex offender Michael Buck receives home detention for child abuse
Her victim statement was read out in the Christchurch District Court by Crown prosecutor Jade Lancaster when Buck appeared for sentencing on multiple charges of sexual conduct with a child aged under 12. The victim said the hardest thing to do was telling her family about Buck's offending. 'I didn't really think anything of it, the damage it might cause, the guilt, talking about it, I still get a sore throat, my heart caves into the pit of my stomach. 'It is heartbreaking, gut-wrenching, it makes me sick now; I have stopped trying to understand why someone like that would take advantage of me, not realising that things like that shouldn't happen to you.' She wanted Buck to acknowledge what he had done. The court heard the victim was often in Buck's care, and that when she was 4 or 5 years old, he had committed an indecent act on her. When the victim was aged between 8 and 9 years old, he again committed an indecent act on her. He went on to deny the offending before saying he didn't have a direct recall of the events, but accepted the summary of facts if that was what the victim had recalled. While defence lawyer Rupert Ward said Buck had shown remorse and taken responsibility for the situation, Judge Gerard Lynch didn't accept his claim of remorse. 'Any remorse was about the fix you found yourself in rather than any heartfelt remorse for this child,' Judge Lynch told him. Judge Lynch said the thought of going back to jail had 'terrified' Buck. Lancaster submitted an uplift in the sentence for Buck's criminal history. 'Obviously this is offending of a type where prison is appropriate.' The Crown also sought to have Buck placed on the Child Sex Offender Register. Judge Lynch said Buck, now 65, had been sentenced to three and half years' jail in 1991 for indecent acts on a girl aged under 12. While there had been more than 30 years between the convictions, it was only 12 years between the offending, the judge said. 'That you have offended again like this is worrying. 'She was very young, you exploited her for your own gratification, it is plain the harm he caused, it will be with her for some time.' Judge Lynch told Buck he did not accept his claim of remorse after Buck had entered not guilty pleas and sought a sentencing indication. From a starting point of 24 months' jail, Judge Lynch sentenced him to 10 months and two weeks' home detention and placed Buck on the Child Sex Offender Register. 'This is the sort of case when an order is needed to protect any children or any other person, the risk is real and genuine.' Al Williams is an Open Justice reporter for the New Zealand Herald, based in Christchurch. He has worked in daily and community titles in New Zealand and overseas for the last 16 years. Most recently he was editor of the Hauraki-Coromandel Post, based in Whangamatā. He was previously deputy editor of the Cook Islands News.
Business Wire
a day ago
- Business
- Business Wire
Bristol Myers Squibb and Bain Capital Create New Company Dedicated to Developing Innovative Immunology Therapies that Address the Unmet Medical Needs of Patients
PRINCETON, N.J. & BOSTON--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY, 'BMS') and Bain Capital today announced the creation of a new independent biopharmaceutical company ('NewCo') focused on developing new therapies for autoimmune diseases that address significant unmet needs of patients. The newly formed company launches with five immunology assets in-licensed from BMS and a $300 million financing commitment that was led by Bain Capital. The NewCo has a broad pipeline consisting of three clinical-stage and two Phase 1-ready investigational medicines that each target promising mechanisms in autoimmune diseases. The most advanced assets in the NewCo's portfolio are afimetoran, an oral, potential best-in-class TLR7/8 inhibitor that is currently being studied in a Phase 2 clinical trial for systemic lupus erythematosus (SLE), and BMS-986322, an oral TYK2 inhibitor, which successfully established proof-of-concept in a positive plaque psoriasis Phase 2 trial. Other licensed assets include BMS-986326, a novel, potential best-in-class, IL2 fusion protein that is currently being studied in Phase 1 clinical trials for SLE and atopic dermatitis, and BMS-986481 and BMS-986498, two Phase 1-ready biologics targeting the IL18 and IL10 pathways respectively. The assets licensed to NewCo reflect the strength of BMS's scientific innovation and hold promise to address unmet needs for patients with autoimmune diseases. As part of the agreement, BMS will retain a nearly 20 percent equity stake in NewCo and will be entitled to royalties and milestones tied to the success of each asset. Robert Plenge, MD, PhD, Executive Vice President and Chief Research Officer at BMS, will also serve on NewCo's Board of Directors. This transaction reflects BMS's strategic shift in Immunology research to focus on assets that have the potential to reset the immune system and promote tissue repair. It also further demonstrates the company's sharpened strategy to invest in areas where BMS is best positioned to lead, while enabling the continued development of promising medicines. 'These assets have significant potential, and we are confident that this new company will drive their development to ensure greater impact for patients,' said Julie Rozenblyum, Senior Vice President, Business Development at BMS. 'Bain Capital's exceptional track record in building successful life science companies by providing focused development and dedicated resources makes them ideally suited to advance these assets to realize their full promise.' Daniel S. Lynch will serve as the Executive Chairman of the Company's Board of Directors and interim CEO. Mr. Lynch is an accomplished biopharmaceutical industry leader with decades of strategic, management and operational experience at companies spanning many stages of growth. Nicholas Downing, MD, Adam M. Koppel, MD, PhD, and Andrew Kaplan from Bain Capital will also join Mr. Lynch and Dr. Plenge of BMS on NewCo's Board of Directors. 'We are excited to partner with BMS and we share their commitment to improving lives through science,' said Adam Koppel, a Partner at Bain Capital Life Sciences. 'We look forward to working together and leveraging our company creation experience to build out this new platform and advance these distinct assets in an effort to bring innovative, high-quality therapies to patients with autoimmune diseases.' 'This is a unique opportunity to build an innovative biotech company with a strong scientific foundation and differentiated development capabilities,' said Mr. Lynch. 'I'm thrilled to have the opportunity to leverage my background and experience to contribute to the success of the company as it seeks to develop much-needed new therapies, and I look forward to supporting BMS and Bain Capital in the build-out of the company's operations.' Bain Capital is investing in NewCo through its Life Sciences and Private Equity teams, drawing on over 40 years of supporting the growth and innovation of healthcare companies globally. Canada Pension Plan Investment Board also joined the investment. About Bristol Myers Squibb: Transforming Patients' Lives Through Science At Bristol Myers Squibb, our mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We are pursuing bold science to define what's possible for the future of medicine and the patients we serve. For more information, visit us at and follow us on LinkedIn, X, YouTube, Facebook and Instagram. Bristol Myers Squibb Cautionary Statement Regarding Forward-Looking Statements This press release contains 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995 regarding, among other things, the research, development and commercialization of pharmaceutical products, the creation of NewCo and the agreement with NewCo. All statements that are not statements of historical facts are, or may be deemed to be, forward-looking statements. Such forward-looking statements are based on current expectations and projections about our future financial results, goals, plans and objectives and involve inherent risks, assumptions and uncertainties, including internal or external factors that could delay, divert or change any of them in the next several years, that are difficult to predict, may be beyond our control and could cause our future financial results, goals, plans and objectives to differ materially from those expressed in, or implied by, the statements. These risks, assumptions, uncertainties and other factors include, among others, that the expected benefits of, and opportunities related to, the creation of NewCo and the agreement with NewCo may not be realized by Bristol Myers Squibb or may take longer to realize than anticipated, that the assets described in this press release, may not achieve their primary study endpoints or receive regulatory approval for the indications described in this release in the currently anticipated timeline or at all and, if approved, whether such assets will be commercially successful. No forward-looking statement can be guaranteed. Forward-looking statements in this press release should be evaluated together with the many risks and uncertainties that affect Bristol Myers Squibb's business and market, particularly those identified in the cautionary statement and risk factors discussion in Bristol Myers Squibb's Annual Report on Form 10-K for the year ended December 31, 2024, as updated by our subsequent Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and other filings with the Securities and Exchange Commission. The forward-looking statements included in this document are made only as of the date of this document and except as otherwise required by applicable law, Bristol Myers Squibb undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, changed circumstances or otherwise. About Bain Capital Founded in 1984, Bain Capital is one of the world's leading private investment firms. We are committed to creating lasting impact for our investors, teams, businesses, and the communities in which we live. As a private partnership, we lead with conviction and a culture of collaboration, advantages that enable us to innovate investment approaches, unlock opportunities, and create exceptional outcomes. Our global platform invests across five focus areas: Private Equity, Growth & Venture, Capital Solutions, Credit & Capital Markets, and Real Assets. In these focus areas, we bring deep sector expertise and wide-ranging capabilities. We have 24 offices on four continents, more than 1,850 employees, and approximately $185 billion in assets under management. To learn more, visit Follow @BainCapital on LinkedIn and X (Twitter). corporatefinancial-news
Fashion Network
2 days ago
- Entertainment
- Fashion Network
Robyn Lynch returns to Brown Thomas for collection launch
Irish designer Robyn Lynch has just launched her latest collection exclusively at Brown Thomas, marking a return to the Dublin high-end department store where she last showcased work before the pandemic. The launch is accompanied by a new in-store installation that 'extends her raw, process-led approach to design and presentation'. This season, Lynch 'revisits and reimagines foundational pieces through her distinctly Irish lens' with garments 'build on familiar forms, but reworked through Lynch's process-driven approach'. The palette moves between muted blacks and browns, punctuated by pops of Dublin blue and vivid flashes of red, colours that 'reflect both her city's subcultural codes and her signature approach to tone and contrast'. A central motif in the collection comes from a graphic adaptation of an 18th-century Saxon alphabet, discovered in a manuscript from the Abbey of Saint-Ouen in Rouen. Lynch says the intricate, serpentine letterforms were originally used in ecclesiastical texts and appear reinterpreted throughout the collection and 'they nod to Ireland's calligraphic heritage and explore the crossover between language, symbolism, and textile'. The collection also builds on visual research first developed in collaboration with fashion laboratory Synflux in 2020. Using scans of vintage GAA jerseys, 'archival graphics have been digitally manipulated, layered, and recontextualised' and it's a process that 'continues a broader conversation within Lynch's work around transformation, national identity, and cyclical design'. The in-store installation also continues Lynch's use of scaffolding-like structures, a 'visual language' she has developed over multiple seasons. This open framework 'reflects her belief in embracing the unfinished' where garments are 'suspended mid-air, as if caught between stages'. 'This set-up offers a glimpse into the mechanics behind the collection and invites the viewer into the space between construction and completion', we're also told. The collection is also available at Brown Thomas Cork and online at the department store's and the designer's webstores.
